Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03317834 · ClinicalTrials.gov registry record
Navio With Total Knee Arthroplasty
A clinical trial, sponsored by Smith & Nephew.
- Completed
- Registry status
- 122
- Enrollment target
NCT03317834: Completed study, sponsored by Smith & Nephew.
NCT03317834 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 122 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03317834 has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 122 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate superior accuracy with the Navio ™ Robotic-assisted Surgical System in achieving desired post-operative mechanical alignment, compared to TKA procedures using standard instruments. An additional study purpose is to document clinical and patient-reported outcomes in subjects receiving TKA with the Navio ™ system.
Primary Outcome
The number of participants achieving post-operative mechanical alignment within ±3 degrees from target with "Yes" indicating mechanical alignment was achieved and "No" indicating mechanical alignment was not achieved.
Interventions
- DEVICE Navio ™ Robotic-assisted Surgical System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2017-11-13 |
| Est. Completion | 2021-05-27 |
What the finished NCT03317834 record still lists
NCT03317834 is an observational study that tracks outcomes without assigning an intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Navio ™ Robotic-assisted Surgical System is the first listed.
NCT03317834 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03317834 about?
NCT03317834 is a clinical study titled "Navio With Total Knee Arthroplasty". The purpose of this study is to demonstrate superior accuracy with the Navio ™ Robotic-assisted Surgical System in achieving desired post-operative mechanical alignment, compared to TKA procedures using standard instruments. An additional study purpose is to document clinical and patient-reported ou...
What is the current status of trial NCT03317834?
This trial is currently completed. The enrollment target is 122 participants. The study started on 2017-11-13. Estimated completion is 2021-05-27.
What interventions are being tested in trial NCT03317834?
The interventions under investigation include: Navio ™ Robotic-assisted Surgical System (DEVICE).
Who is sponsoring clinical trial NCT03317834?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03363373 · 122 participants · Phase 2
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
- NCT03463954 · 122 participants · NA
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
- NCT04503265 · 122 participants · Phase 1
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- NCT04700527 · 122 participants · Phase 1
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI